A Concept-informed Interpretable Artificial Intelligence Framework for Breast Ultrasound Diagnosis

By Zhong, Wang, Li +14Oct 12, 2026

Score███░░░░░░░3.5

Key numbers

9,941 patients

VerdictWorth a reader's time today.

Read the original PDF Code

Abstract

Most existing artificial intelligence systems for breast ultrasound rely primarily on image-driven prediction, with limited incorporation of the knowledge from the Breast Imaging Reporting and Data System (BI-RADS) and the intermediate assessment processes underlying radiologists' workflow, thereby constraining their interpretability and alignment with clinical practice. We curated, to our knowledge, the largest multicenter collection of breast ultrasound images paired with structured BI-RADS descriptors, comprising 9,941 patients across 20 independent datasets. Across 14 testing datasets, IBUS demonstrated consistent generalization performance across different clinical centers and imaging conditions. Incorporating BI-RADS descriptors enabled fine-grained risk stratification, while cross-checking predicted BI-RADS grades against malignancy probabilities identified internally discordant predictions that may warrant additional clinical review. In a reader study involving eight radiologists, IBUS assistance increased diagnostic sensitivity among both junior and senior readers, with the potential of guiding radiologists to make targeted revision in risk stratification. Overall, IBUS exhibits its potential as a second-stage decision-support system that complements radiologists by providing additional risk estimates and interpretable evidence for diagnostically challenging cases. The demo video of IBUS platform is publicly available at https://github.com/zsz1997/IBUS.

Shengzhou Zhong, Ziying Wang, Liang Li, Lihua Yan, Shuochun Chen, Yudie Zou, Jifan Zhang, Wenhao Li, Huiling Zhang, Jiayin Lu, Ziting Xu, Qianjin Feng, Zhenwei Shi, Yan Chen, Yingjia Li, Yu Zhang, Zhenyuan Ning

The editor's rubric

Heuristic review

Dimension	Level	Weight	What that level means
Leverage	████░ 4	24%	A general-purpose tool used across several fields (Adam, ResNet, LoRA, next-generation sequencing).
Magnitude	██░░░ 2	18%	Solid incremental gain on a meaningful problem.
Evidence	█████ 5	14%	Definitive: phase 3 randomized evidence on hard endpoints, multi-lab replication, or community verification at scale.
Novelty	██░░░ 2	16%	A new combination of known ideas.
Trajectory	███░░ 3	18%	A clear path to scale.
Stakes	██░░░ 2	10%	Benefits a professional community (practitioners, clinicians, engineers).

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: breadth (many tasks, programmable); design (multicenter); verification (multiple benchmarks, independent replication, code released); stakes (general AI).

How the score was computed

rank-2026-10-07

Score███░░░░░░░3.5

Score = 10 × (65% × adjusted merit / 10 + 25% × attention + 10% × freshness)

Merit: 6.2 / 10; Weighted rubric, evidence-gated.
Adjusted merit: 4.9 / 10; Shrunk toward the desk prior by editor confidence (42%).
Attention: 0%; Citations, upvotes, points, mentions.
Freshness: 26%; Half-life decay since publication.

Citations0 (reference 15, via semantic-scholar, Oct 15, 2026, 06:17 UTC)
Influential citations0 (reference 3, via semantic-scholar, Oct 15, 2026, 06:17 UTC)

The record

Reviewed by heuristic-v2 on Oct 16, 2026, 13:29 UTC. Paper type: clinical.
Categories: cs.CV
BRIEF, No.3 in the Medicine edition of October 17, 2026.